Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherven Sharma

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 10, 2012
Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cellsMiranda Dennis, Guanyu Wang, Jie Luo, et al.
Human Gene Therapy|October 28, 2003
Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinomaSherven Sharma, Raj K Batra, Seok Chul Yang, et al.
Plos One|October 27, 2010
Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cellsInes Herrmann, Patrick A Baeuerle, Matthias Friedrich, et al.
Anticancer Research|April 9, 2005
The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in boneSeth C Gamradt, Brian T Feeley, Nancy Q Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancerAsa Andersson, Seok-Chul Yang, Min Huang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 15, 2014
A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine modelYuan Lin, Jie Luo, Weichao Eric Zhu, et al.
Journal of Translational Medicine|July 23, 2008
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancerFelicita Baratelli, Hiroko Takedatsu, Saswati Hazra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherinKaren L Reckamp, Brian K Gardner, Robert A Figlin, et al.
American Journal of Respiratory Cell and Molecular Biology|January 24, 2014
Immunotherapy for malignant pleural mesothelioma. Current status and future prospectsRaymond M Wong, Irina Ianculescu, Sherven Sharma, et al.
Oral Oncology|August 18, 2016
p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinomaYuan Lin, Jon Mallen-St Clair, Guanyu Wang, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 10, 2012
Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cellsMiranda Dennis, Guanyu Wang, Jie Luo, et al.
Human Gene Therapy|October 28, 2003
Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinomaSherven Sharma, Raj K Batra, Seok Chul Yang, et al.
Plos One|October 27, 2010
Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cellsInes Herrmann, Patrick A Baeuerle, Matthias Friedrich, et al.
Anticancer Research|April 9, 2005
The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in boneSeth C Gamradt, Brian T Feeley, Nancy Q Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancerAsa Andersson, Seok-Chul Yang, Min Huang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 15, 2014
A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine modelYuan Lin, Jie Luo, Weichao Eric Zhu, et al.
Journal of Translational Medicine|July 23, 2008
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancerFelicita Baratelli, Hiroko Takedatsu, Saswati Hazra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherinKaren L Reckamp, Brian K Gardner, Robert A Figlin, et al.
American Journal of Respiratory Cell and Molecular Biology|January 24, 2014
Immunotherapy for malignant pleural mesothelioma. Current status and future prospectsRaymond M Wong, Irina Ianculescu, Sherven Sharma, et al.
Oral Oncology|August 18, 2016
p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinomaYuan Lin, Jon Mallen-St Clair, Guanyu Wang, et al.
Pageof 11